NCT06814912

Brief Summary

Use of virtula reality headsets during treatment course on day hospitalized cancer patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Jun 2024

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
Last Updated

February 7, 2025

Status Verified

January 1, 2025

Enrollment Period

8 months

First QC Date

January 20, 2025

Last Update Submit

February 4, 2025

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

  • Rate of patients with nausea reduction compared with preview treatment administration

    survey : improvement of nausea

    From the first chemotherapy injection until the end of chemotherapy injection with the virtual reality headset (at the end of the third cycle; each cycle is 21 days) )

Study Arms (1)

virtual reality headset

EXPERIMENTAL
Other: Survey using a questionnaire

Interventions

Survey using a questionnaireOTHER

virtual reality headset is added during treatment administration. Patient must complete a survey at the end of treatment administration and virtual headset use.

virtual reality headset

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • cancer patients
  • chemotherapy treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ICAP

Avignon, 84918, France

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2025

First Posted

February 7, 2025

Study Start

June 1, 2024

Primary Completion

January 20, 2025

Study Completion

January 20, 2025

Last Updated

February 7, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)